Akute Myopisierung nach einer Einzeldosis Acetazolamid: Fallbericht und Literaturrecherche [Acute Myopic Shift after a Single Dose of Acetazolamide: A Case Report and Review of the Literature]

Details

Serval ID
serval:BIB_3A636D04C5DC
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Akute Myopisierung nach einer Einzeldosis Acetazolamid: Fallbericht und Literaturrecherche [Acute Myopic Shift after a Single Dose of Acetazolamide: A Case Report and Review of the Literature]
Journal
Klinische Monatsblatter fur Augenheilkunde
Author(s)
Kaisari E., Abouzeid H., Magnin L., Boeuf M., Gkaragkani E., Schalenbourg A., Wolfensberger T.J., Kaeser P.F.
ISSN
1439-3999 (Electronic)
ISSN-L
0023-2165
Publication state
Published
Issued date
04/2024
Peer-reviewed
Oui
Volume
241
Number
4
Pages
554-558
Language
english
Notes
Publication types: Journal Article ; Case Reports ; Review
Publication Status: ppublish
Abstract
We report the case of a 32-year-old male who presented with an acute myopic shift as a result of uveal effusion following a single administration of 250 mg acetazolamide. The drug was discontinued and following cycloplegia and topical steroid therapy, we observed progressive deepening of the anterior chamber, reopening of the iridocorneal angle, and complete resolution of the myopic shift after 5 days. A literature review since 1956 identified 23 cases, including ours, which developed a myopic shift after a median time of 24 h (3 - 24) following a median dose of 500 mg (125 - 1000) acetazolamide, with about a third complicated by angle closure ocular hypertension. This presumed idiosyncratic reaction can occur without prior drug exposure and independent of the phakic status. Treatment options include systematic drug withdrawal associated with cycloplegia, anti-glaucomatous agents, and/or corticosteroids. Full recovery is achieved within about 5 days (2 - 14). Given the widespread use of acetazolamide, awareness of this idiosyncratic reaction is crucial to avoid complications of acute angle-closure glaucoma.
Keywords
Humans, Acetazolamide/therapeutic use, Acetazolamide/adverse effects, Acetazolamide/administration & dosage, Male, Adult, Myopia/chemically induced, Myopia/drug therapy, Carbonic Anhydrase Inhibitors/adverse effects, Carbonic Anhydrase Inhibitors/administration & dosage, Carbonic Anhydrase Inhibitors/therapeutic use, Acute Disease, Treatment Outcome
Pubmed
Open Access
Yes
Create date
29/04/2024 10:01
Last modification date
30/04/2024 7:06
Usage data